The microbiome and precision oncology: an emerging paradigm in anticancer therapy

References

• Author. 2010. Human genome at ten: the sequence explosion. Nature. 464(7289):670–671.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, Caldas C, Califano A, Doherty M, Elsner M, et al. 2015. Toward understanding and exploiting tumor heterogeneity. Nat Med. 21(8):846–853.
   PubMed Web of Science ®Google Scholar
• Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JS-G, Gómez-Millán J, Yucel G, Lara MF. 2018. The Urinary Tract Microbiome in health and disease. Eur Urol Focus. 4(1):128–138.
   PubMedGoogle Scholar
• Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, Shadaloey SA, Wu D, Preiss P, Verma N, et al. 2019. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 574(7777):264–267.
   PubMed Web of Science ®Google Scholar
• Azzam EI, Little JB. 2004. The radiation-induced bystander effect: evidence and significance. Hum Exp Toxicol. 23(2):61–65.
   PubMed Web of Science ®Google Scholar
• Baird JR, Friedman D, Cottam B, Dubensky TW, Kanne DB, Bambina S, Bahjat K, Crittenden MR, Gough MJ. 2016. Radiotherapy combined with Novel STING-targeting oligonucleotides results in regression of established tumors. Cancer Res. 76(1):50–61.
   PubMed Web of Science ®Google Scholar
• Barker HE, Paget JTE, Khan AA, Harrington KJ. 2015. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 15(7):409–425.
   PubMed Web of Science ®Google Scholar
• Bindels LB, Delzenne NM. 2013. Muscle wasting: the gut microbiota as a new therapeutic target? Int J Biochem Cell Biol. 45(10):2186–2190.
   PubMed Web of Science ®Google Scholar
• Blaser MJ. 2008. Understanding microbe-induced cancers. Cancer Prev Res. 1(1):15–20.
   PubMed Web of Science ®Google Scholar
• Bogenrieder T, Herlyn M. 2003. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 22(42):6524–6536.
   PubMed Web of Science ®Google Scholar
• Brandi G, Dabard J, Raibaud P, Di Battista M, Bridonneau C, Pisi AM, Morselli Labate AM, Pantaleo MA, De Vivo A, Biasco G, et al. 2006. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin Cancer Res. 12(4):1299–1307.
   PubMed Web of Science ®Google Scholar
• Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T, et al. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 434(7035):913–917.
   PubMed Web of Science ®Google Scholar
• Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. 2009. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem. 16(25):3267–3285.
   PubMed Web of Science ®Google Scholar
• Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, Liang D-C, Shau W-Y, Chen D-S. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 336(26):1855–1859.
   PubMed Web of Science ®Google Scholar
• Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Nava GM, Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF, et al. 2012. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut. 61(6):829–838.
   PubMed Web of Science ®Google Scholar
• Cramer P, Bresalier RS. 2017. Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors. Curr Gastroenterol Rep. 19(1):3.
   PubMedGoogle Scholar
• Crawford PA, Gordon JI. 2005. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA. 102(37):13254–13259.
   PubMed Web of Science ®Google Scholar
• Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, Zheng Q, Dong J, Zhao Y, Zhang X, et al. 2017. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med. 9(4):448–461.
   PubMed Web of Science ®Google Scholar
• Cyranoski D. 2016. CRISPR gene-editing tested in a person for the first time. Nature. 539(7630):479.
   PubMed Web of Science ®Google Scholar
• Daillere R, Vetizou M, et al. 2016. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 45(4):931–943.
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Erturk-Hasdemir D, Ochoa-Reparaz J, Reinecker H-C, Kasper DL. 2014. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe. 15(4):413–423.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505(7484):559–563.
   PubMed Web of Science ®Google Scholar
• de Klerk N, Maudsdotter L, Gebreegziabher H, Saroj SD, Eriksson B, Eriksson OS, Roos S, Lindén S, Sjölinder H, Jonsson A-B, et al. 2016. Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression. Infect Immun. 84(5):1526–1535.
   PubMed Web of Science ®Google Scholar
• Delia P, Sansotta G, et al. 2007. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 13(6):912–915.
   PubMed Web of Science ®Google Scholar
• Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC. 2004. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 58(3):862–870.
   PubMed Web of Science ®Google Scholar
• Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu Y-X. 2014. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 124(2):687–695.
   PubMed Web of Science ®Google Scholar
• Derer A, Deloch L, Rubner Y, Fietkau R, Frey B, Gaipl US. 2015. Radio-Immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses - pre-clinical evidence and ongoing clinical applications. Front Immunol. 6:505.
   PubMed Web of Science ®Google Scholar
• Do K, O’Sullivan Coyne G, et al. 2015. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. Chin Clin Oncol. 4(3):31.
   PubMedGoogle Scholar
• Donaldson GP, Lee SM, Mazmanian SK. 2016. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 14(1):20–32.
   PubMed Web of Science ®Google Scholar
• Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C, et al. 2016. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 7:10391.
   PubMed Web of Science ®Google Scholar
• ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. 2014. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. Omics. 18(7):402–414.
   PubMed Web of Science ®Google Scholar
• Faust K, Lahti L, Gonze D, de Vos WM, Raes J. 2015. Metagenomics meets time series analysis: unraveling microbial community dynamics. Curr Opin Microbiol. 25:56–66.
   PubMed Web of Science ®Google Scholar
• Ferreira MR, Muls A, Dearnaley DP, Andreyev HJN. 2014. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncol. 15(3):e139-147–e147.
   Web of Science ®Google Scholar
• Flemer B, Lynch DB, Brown JMR, Jeffery IB, Ryan FJ, Claesson MJ, O’Riordain M, Shanahan F, O’Toole PW. 2017. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut. 66(4):633–643.
   PubMed Web of Science ®Google Scholar
• Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, et al. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 361(2):123–134.
   PubMed Web of Science ®Google Scholar
• Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. 2017. The evolution of the host microbiome as an ecosystem on a leash. Nature. 548(7665):43–51.
   PubMed Web of Science ®Google Scholar
• Franzosa EA, Huang K, Meadow JF, Gevers D, Lemon KP, Bohannan BJM, Huttenhower C. 2015. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci USA. 112(22):E2930–2938.
   PubMed Web of Science ®Google Scholar
• Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, et al. 2017. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 357(6356):1156–1160.
   PubMed Web of Science ®Google Scholar
• Genton L, Mareschal J, Charretier Y, Lazarevic V, Bindels LB, Schrenzel J. 2019. Targeting the gut microbiota to treat Cachexia. Front Cell Infect Microbiol. 9:305.
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Swanton C. 2010. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer. 103(8):1139–1143.
   PubMed Web of Science ®Google Scholar
• Ginsburg GS. 2013. Realizing the opportunities of genomics in health care. JAMA. 309(14):1463–1464.
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Hagerling C, Werb Z. 2018. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 32(19-20):1267–1284.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 359(6371):97–103.
   PubMed Web of Science ®Google Scholar
• Green JM, Barratt MJ, Kinch M, Gordon JI. 2017. Food and microbiota in the FDA regulatory framework. Science. 357(6346):39–40.
   PubMed Web of Science ®Google Scholar
• Grootaert C, Van de Wiele T, Van Roosbroeck I, Possemiers S, Vercoutter-Edouart A-S, Verstraete W, Bracke M, Vanhoecke B. 2011. Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines. Environ Microbiol. 13(7):1778–1789.
   PubMed Web of Science ®Google Scholar
• Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP. 2005. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65(8):3437–3446.
   PubMed Web of Science ®Google Scholar
• He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, et al. 2021. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 33(5):988–1000.e7.
   PubMed Web of Science ®Google Scholar
• Herremans KM, Riner AN, Cameron ME, Trevino JG. 2019. The microbiota and cancer cachexia. Int J Mol Sci. 20(24):6267.
   Web of Science ®Google Scholar
• Heshiki Y, Vazquez-Uribe R, Li J, Ni Y, Quainoo S, Imamovic L, Li J, Sørensen M, Chow BKC, Weiss GJ, et al. 2020. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome. 8(1):28.
   PubMed Web of Science ®Google Scholar
• Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, et al. 2013. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 342(6161):967–970.
   PubMed Web of Science ®Google Scholar
• Jones RM, Desai C, Darby TM, Luo L, Wolfarth AA, Scharer CD, Ardita CS, Reedy AR, Keebaugh ES, Neish AS, et al. 2015. Lactobacilli modulate epithelial cytoprotection through the Nrf2 Pathway. Cell Rep. 12(8):1217–1225.
   PubMed Web of Science ®Google Scholar
• Jones RM, Luo L, Ardita CS, Richardson AN, Kwon YM, Mercante JW, Alam A, Gates CL, Wu H, Swanson PA, et al. 2013. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. Embo J. 32(23):3017–3028.
   PubMed Web of Science ®Google Scholar
• Klein GL, Petschow BW, Shaw AL, Weaver E. 2013. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat Care. 7(4):361–367.
   PubMed Web of Science ®Google Scholar
• Krishnan K, Chen T, Paster BJ. 2017. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 23(3):276–286.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. 2013. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 31:51–72.
   PubMed Web of Science ®Google Scholar
• Lax AJ, Thomas W. 2002. How bacteria could cause cancer: one step at a time. Trends Microbiol. 10(6):293–299.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee Y, Kim J, An J, Lee S, Kong H, Song Y, Lee C-K, Kim K. 2018. Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes. 9(2):155–165.
   PubMed Web of Science ®Google Scholar
• Lin XB, Dieleman LA, Ketabi A, Bibova I, Sawyer MB, Xue H, Field CJ, Baracos VE, Gänzle MG. 2012. Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS One. 7(7):e39764.
   PubMed Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 2003. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 3(5):330–338.
   PubMed Web of Science ®Google Scholar
• Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, Luke JJ, Gajewski TF. 2018. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 359(6371):104–108.
   PubMed Web of Science ®Google Scholar
• Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin L, et al. 2020. Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys. 107(1):163–171.
   PubMed Web of Science ®Google Scholar
• Moffatt MF, Cookson WO. 2017. The lung microbiome in health and disease. Clin Med. 17(6):525–529.
   PubMed Web of Science ®Google Scholar
• Mullard A. 2015. NCI-MATCH trial pushes cancer umbrella trial paradigm. Nat Rev Drug Discov. 14(8):513–515.
   PubMed Web of Science ®Google Scholar
• Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. 2020. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 368(6494):973–980.
   PubMed Web of Science ®Google Scholar
• Nigro G, Rossi R, Commere P-H, Jay P, Sansonetti PJ. 2014. The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration. Cell Host Microbe. 15(6):792–798.
   PubMed Web of Science ®Google Scholar
• Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell E, Nuciforo P, Moreno V, et al. 2021. Tumor-associated microbiome: where do we stand? IJMS. 22(3):1446.
   Google Scholar
• Ó Broin P, Vaitheesvaran B, Saha S, Hartil K, Chen EI, Goldman D, Fleming WH, Kurland IJ, Guha C, Golden A, et al. 2015. Intestinal microbiota-derived metabolomic blood plasma markers for prior radiation injury. Int J Radiat Oncol Biol Phys. 91(2):360–367.
   PubMed Web of Science ®Google Scholar
• Parsonnet J. 1995. Bacterial infection as a cause of cancer. Environ Health Perspect. 103 Suppl 8 (Suppl 8):263–268.
   PubMedGoogle Scholar
• Peek RM, Jr., Blaser MJ. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2(1):28–37.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Vétizou M, Waldschmitt N, Kroemer G, Chamaillard M, Boneca IG, Zitvogel L. 2016. Fine-tuning cancer immunotherapy: optimizing the gut microbiome. Cancer Res. 76(16):4602–4607.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, et al. 2016. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity. 44(6):1255–1269.
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A, Abad-Diaz-de-Cerio A, Hernando FL. 2016. Candida albicans and cancer: can this yeast induce cancer development or progression? Crit Rev Microbiol. 42(2):181–193.
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia A, Arteta B, Abad-Diaz-de-Cerio A, Pellon A, Antoran A, Marquez J, Rementeria A, Hernando FL. 2013. Candida albicans increases tumor cell adhesion to endothelial cells in vitro: intraspecific differences and importance of the mannose receptor. PloS One. 8(1):e53584.
   PubMed Web of Science ®Google Scholar
• Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J. 2008. Prodrugs: design and clinical applications. Nat Rev Drug Discov. 7(3):255–270.
   PubMed Web of Science ®Google Scholar
• Rigby RJ, Carr J, Orgel K, King SL, Lund PK, Dekaney CM. 2016. Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis. Gut Microbes. 7(5):414–423.
   PubMed Web of Science ®Google Scholar
• Roberts AB, Wallace BD, Venkatesh MK, Mani S, Redinbo MR. 2013. Molecular insights into microbial beta-glucuronidase inhibition to abrogate CPT-11 toxicity. Mol Pharmacol. 84(2):208–217.
   PubMed Web of Science ®Google Scholar
• Rolston KV. 2017. Infections in cancer patients with solid tumors: a review. Infect Dis Ther. 6(1):69–83.
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. 2018. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 359(6371):91–97.
   PubMed Web of Science ®Google Scholar
• Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, et al. 2000. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 343(13):905–914.
   PubMed Web of Science ®Google Scholar
• Saussele S, Krauss M-P, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, Fabarius A, Kraemer D, Berdel WE, et al. 2015. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV. Blood. 126(1):42–49.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet. 370(9590):890–907.
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. 2016. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 164(3):337–340.
   PubMed Web of Science ®Google Scholar
• Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. 2012. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. 48(6):875–881.
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. 2015. The future of immune checkpoint therapy. Science. 348(6230):56–61.
   PubMed Web of Science ®Google Scholar
• Sheflin AM, Whitney AK, Weir TL. 2014. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 16(10):406.
   PubMed Web of Science ®Google Scholar
• Shin SH, Bode AM, Dong Z. 2017. Precision medicine: the foundation of future cancer therapeutics. NPJ Precis Oncol. 1(1):12.
   PubMedGoogle Scholar
• Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K, Fu Y, Weichselbaum RR, Zhao X, Wang L, et al. 2021. Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2021:gutjnl-2020-323426.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA A Cancer J Clin. 70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre M-L, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350(6264):1084–1089.
   PubMed Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, Carlsson A, Abrahamsson B, Basit AW. 2008. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 363(1–2):1–25.
   PubMed Web of Science ®Google Scholar
• Stewart CA, Metheny H, Iida N, Smith L, Hanson M, Steinhagen F, Leighty RM, Roers A, Karp CL, Müller W, et al. 2013. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. J Clin Invest. 123(11):4859–4874.
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh ASJ, Hamilton J, Keefe DMK. 2009. Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med. 234(4):430–441.
   PubMed Web of Science ®Google Scholar
• Stringer AM, Gibson RJ, Bowen JM, Logan RM, Ashton K, Yeoh ASJ, Al-Dasooqi N, Keefe DMK. 2009. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol. 90(5):489–499.
   PubMed Web of Science ®Google Scholar
• Sun Y-Z, Zhang D-H, Cai S-B, Ming Z, Li J-Q, Chen X. 2018. MDAD: a special resource for microbe-drug associations. Front Cell Infect Microbiol. 8:424.
   PubMed Web of Science ®Google Scholar
• Testa MM, Ruiz de Valladares R, Benito de Cardenas IL. 2003. Antagonistic interactions among Fusobacterium nucleatum and Prevotella intermedia with oral lactobacilli. Res Microbiol. 154(10):669–675.
   PubMed Web of Science ®Google Scholar
• Thomas T, Gilbert J, Meyer F. 2012. Metagenomics – a guide from sampling to data analysis. Microb Inform Exp. 2(1):3.
   PubMedGoogle Scholar
• Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, Bruley Des Varannes S, Le Vacon F, de La Cochetière MF. 2014. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis – current evidence and potential clinical applications. Aliment Pharmacol Ther. 40(5):409–421.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The human microbiome project. Nature. 449(7164):804–810.
   PubMed Web of Science ®Google Scholar
• Uribe-Herranz M, Rafail S, Beghi S, Gil-de-Gómez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini S, Perales-Linares R, Blair IA, et al. 2020. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. J Clin Invest. 130(1):466–479.
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JFWM, Tijssen JGP, et al. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 368(5):407–415.
   PubMed Web of Science ®Google Scholar
• Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh D-Y, Diéras V, Guardino E, et al. 2012. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 367(19):1783–1791.
   PubMed Web of Science ®Google Scholar
• Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CPM, et al. 2015. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 350(6264):1079–1084.
   PubMed Web of Science ®Google Scholar
• Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, et al. 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 342(6161):971–976.
   PubMed Web of Science ®Google Scholar
• Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh L-A, Mani S, et al. 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 330(6005):831–835.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 153(4):910–918.
   PubMed Web of Science ®Google Scholar
• Wu J, Li Q, Fu X. 2019. Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity. Transl Oncol. 12(6):846–851.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhu W, Thompson P, Hannun YA. 2018. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun. 9(1):3490.
   PubMedGoogle Scholar
• Yamamura K, Baba Y, Miyake K, Nakamura K, Shigaki H, Mima K, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, et al. 2017. Fusobacterium nucleatum in gastroenterological cancer: evaluation of measurement methods using quantitative polymerase chain reaction and a literature review. Oncol Lett. 14(6):6373–6378.
   PubMed Web of Science ®Google Scholar
• Yeh K-Y, Wang H-M, Chang JW-C, Huang J-S, Lai C-H, Lan Y-J, Wu T-H, Chang P-H, Wang H, Wu C-J, et al. 2013. Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 116(1):41–48.
   PubMed Web of Science ®Google Scholar
• Yi SY, Park YS, Kim HS, Jun HJ, Kim KH, Chang MH, Park MJ, Uhm JE, Lee J, Park SH, et al. 2009. Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer. Cancer Chemother Pharmacol. 63(6):1141–1145.
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al. 2017. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 170(3):548–563 e516.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Butcher J, Stintzi A, Figeys D. 2019. Advancing functional and translational microbiome research using meta-omics approaches. Microbiome. 7(1):154.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Cheng W, Qu W, Shao G, Liu S. 2020. Antibiotic alleviates radiation-induced intestinal injury by remodeling microbiota, reducing inflammation, and inhibiting fibrosis. ACS Omega. 5(6):2967–2977.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. 2017. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 15(8):465–478.
   PubMed Web of Science ®Google Scholar
• Zou Y, Xue W, Luo G, Deng Z, Qin P, Guo R, Sun H, Xia Y, Liang S, Dai Y, et al. 2019. 1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses. Nat Biotechnol. 37(2):179–185.
   PubMed Web of Science ®Google Scholar